Abbonarsi

Mesohepatectomy - 05/09/11

Doi : 10.1016/S0002-9610(00)00374-3 
Charles H Scudamore, MD, MSc a, ⁎, Andrzej K Buczkowski, MD a, Hossein Shayan, MSc a, Stephen G.F Ho, MD b, Gerald M Legiehn, MD b, Stephen W Chung, MD, PhD a, David A Owen, MB c
a Department of Surgery (CHS, AKB, HS, SWC), Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada 
b Department of Radiology (SDFH, GML), Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada 
c Department of Pathology and Laboratory Medicine (DAO), Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada 

*Requests for reprints should be addressed to Charles H. Scudamore, MD, Head, Section of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Vancouver Hospital and Health Sciences Center, 910 West 10th Avenue, 3rd Floor, Vancouver, British Columbia, Canada V5Z 4E3

Abstract

Background: Formal anatomic (lobar) or extended hepatectomies are recommended for liver malignancies located centrally within the liver (Couinaud’s segments IVA, IVB, V, and VIII). Mesohepatectomy, resection of central hepatic segments and leaving the right and left segments in situ, removes large central tumors preserving more functioning liver tissue than either extended left or right hepatectomy. Mesohepatectomy is a seldom used, technically demanding procedure, and its application is yet to be defined.

Methods: Medical charts of 244 consecutive liver resection patients were reviewed retrospectively. Eighteen patients were treated with mesohepatectomy. Six patients had metastatic liver tumor (MLT), 11 had hepatocellular carcinoma (HCC), and 1 had gallbladder adenocarcinoma. The operative results were compared with groups of patients treated by lobar hepatectomy (n = 71) and extended left or right hepatectomy (n = 43).

Results: The mean mesohepatectomy operative time was 238 versus 304 minutes in the extended group. Inflow occlusion mean time was longer in the mesohepatectomy group than in extended procedures, 45 versus 39 minutes (P = not significant). Comparing the extended hepatectomy group, the mesohepatectomy group had a mean operative estimated blood loss 914 cc versus 1628 cc (P <0.01), postoperative hospital stay 9 versus 16 days (P = 0.054) and volume of resected liver 560cc versus 1500cc (P <0.01) respectively. The late complication rate was lower in the mesohepatectomy group than in the extended group and was comparable to the lobar hepatectomy group (P = 0.05).

Conclusions: Despite its technical demands, mesohepatectomy should be considered as an alternative to extended hepatectomy for selected patients with primary and secondary hepatic tumors localized in middle liver segments, as its complication rate, postoperative recovery, and preserved liver tissue compare favorably with extended hepatic resection.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2000  Excerpta Medica Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 179 - N° 5

P. 356-360 - maggio 2000 Ritorno al numero
Articolo precedente Articolo precedente
  • Computed tomography severity index is a predictor of outcomes for severe pancreatitis
  • Erik J Simchuk, L.William Traverso, Yuji Nukui, Richard A Kozarek
| Articolo seguente Articolo seguente
  • The microbiology of necrotizing soft tissue infections
  • David Elliott, Joseph A Kufera, Roy A.M Myers

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.